Offer - Urjas Oil for just ₹ 1 X
Loratadine + Nimesulide + Phenylephrine + Ambroxol is an allopathic medicine The correct dosage of Loratadine + Nimesulide + Phenylephrine + Ambroxol depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Loratadine + Nimesulide + Phenylephrine + Ambroxol is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Loratadine + Nimesulide + Phenylephrine + Ambroxol is used -
Severe
Moderate
Mild
Common
Is the use of Loratadine + Nimesulide + Phenylephrine + Ambroxol safe for pregnant women?
It is not known what effect Loratadine + Nimesulide + Phenylephrine + Ambroxol will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Loratadine + Nimesulide + Phenylephrine + Ambroxol safe during breastfeeding?
There is no research available on the side effects of Loratadine + Nimesulide + Phenylephrine + Ambroxol in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Loratadine + Nimesulide + Phenylephrine + Ambroxol on the Kidneys?
Loratadine + Nimesulide + Phenylephrine + Ambroxol has very mild side effects on the kidneys.
What is the effect of Loratadine + Nimesulide + Phenylephrine + Ambroxol on the Liver?
The liver can be affected by Loratadine + Nimesulide + Phenylephrine + Ambroxol. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Loratadine + Nimesulide + Phenylephrine + Ambroxol only after medical advice.
What is the effect of Loratadine + Nimesulide + Phenylephrine + Ambroxol on the Heart?
Loratadine + Nimesulide + Phenylephrine + Ambroxol is rarely harmful for the heart.
Loratadine + Nimesulide + Phenylephrine + Ambroxol should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Loratadine + Nimesulide + Phenylephrine + Ambroxol unless your doctor advises you to do so -
Is this Loratadine + Nimesulide + Phenylephrine + Ambroxol habit forming or addictive?
Loratadine + Nimesulide + Phenylephrine + Ambroxol is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Loratadine + Nimesulide + Phenylephrine + Ambroxol as you may feel sleepy.
Is it safe?
Yes, Loratadine + Nimesulide + Phenylephrine + Ambroxol is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Loratadine + Nimesulide + Phenylephrine + Ambroxol cannot treat any kind of mental disorder.
Interaction between Food and Loratadine + Nimesulide + Phenylephrine + Ambroxol
There isn't any research available on the side effects of taking Loratadine + Nimesulide + Phenylephrine + Ambroxol with food.
Interaction between Alcohol and Loratadine + Nimesulide + Phenylephrine + Ambroxol
Taking alcohol with Loratadine + Nimesulide + Phenylephrine + Ambroxol can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Claritin® (loratadine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,166
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 790-791
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 203-204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Vazculep (phenylephrine hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 135-136
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1020-1022
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219